ARCHIVES

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 23 | June 18, 2010

Download PDF Visit The Full Archive

Related Articles

Controlling Diabetes May Cut Liver Cancer Risk, Study Finds

April 30, 2010

NCI Grant Boosts UCLA Bladder Cancer Project

October 25, 2002

In Brief: Pass Joins Karmanos Cancer Institute; Nag President-Elect, Brachytherapy Society

June 27, 1997

FDA Places Controls On Silicone Implants, Though Still Available For Reconstruction

April 25, 1992

2006 demonstration project to pay $23 per office visit.

November 4, 2005

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009